Comparative Biosciences, Inc

Who We Are

Welcome to Comparative Biosciences, Inc. (CBI)—your trusted partner in the realm of preclinical research. As a proud member of the Genesis Biotechnology Group, CBI is at the forefront of innovation in biomedical and biopharmaceutical research. Since our inception, we have dedicated ourselves to providing exemplary preclinical toxicology and pharmacokinetics services, along with efficacy studies across multiple therapeutic areas. Our state-of-the-art facilities are AAALAC accredited and we are registered with the FDA, USDA, and OLAW, ensuring that our work meets the highest standards of quality and compliance.

What sets us apart is our unwavering commitment to advancing scientific knowledge and crafting solutions that translate seamlessly from the laboratory to real-world applications. Our team of dedicated scientists and researchers possesses specialized expertise in diverse fields, including dermatology, ophthalmology, oncology, wound healing, inflammation, cardiovascular disease, and infectious diseases. We take pride in our collaborative approach and tailor our services to meet the unique needs of each client.

What We Do

At CBI, we offer a comprehensive suite of preclinical services designed to support the vast landscape of biomedical research. Our offerings include preclinical toxicology and pharmacokinetics studies, which are pivotal for assessing the safety and efficacy of new therapeutic compounds before they advance to clinical trials. We also specialize in efficacy studies, providing critical insights into the therapeutic potential of investigational drugs.

Our expertise spans several key areas:

• Dermatology: From hypertrophic scar formation to psoriasis models, we provide in-depth analysis of dermatological conditions.
• Ophthalmology: Our intraocular lens studies and other ophthalmic models support cutting-edge research in eye health.
• Oncology: We have pioneered studies on oncolytic viral vaccines and chimeric poxvirus therapies aimed at combating cancer.
• Wound Healing & Inflammation: We offer robust models for studying tissue repair and inflammatory responses.
• Cardiovascular & Infectious Diseases: Our work includes innovative approaches to treating conditions such as COVID-19 and other viral infections.

We continually invest in expanding our capabilities—evident from our recent acquisitions which have enhanced our chemistry services portfolio and clinical services offerings.

Why You Should Use Us

Choosing CBI as your research partner opens the door to a world of scientific excellence and innovation. Here’s why you should consider collaborating with us:

Unparalleled Expertise: Our team comprises seasoned professionals with decades of experience in their respective fields. Their expertise ensures that your research is in capable hands.

Comprehensive Services: We offer an all-encompassing range of preclinical services. Our holistic approach ensures seamless transitions from preclinical studies to clinical development phases.

Commitment to Quality: As an AAALAC accredited facility, we adhere to stringent quality standards. Our compliance with FDA, USDA, and OLAW regulations underscores our dedication to maintaining the highest levels of integrity and reliability.

Innovative Collaborations: Being a part of Genesis Global Group allows us access to a wider network of resources and expertise. This collaboration enhances our ability to deliver cutting-edge solutions tailored to your research needs.

Client-Centric Approach: At CBI, we prioritize our clients’ needs. Our personalized service ensures that we understand your specific objectives and work meticulously towards achieving them.

What Can You Ask?

We understand that navigating the complexities of preclinical research can be daunting. That’s why we invite you to reach out with any questions you might have. Here are just a few examples of what you can ask us:

• What preclinical models would best suit my specific research needs?
• How can CBI assist in transitioning from preclinical to clinical phases?
• What are the regulatory requirements for my study and how does CBI ensure compliance?
• Can you provide insights into recent advancements in oncolytic viral therapies?
• How do you ensure the ethical treatment of animals in your research?
• What are the timelines for conducting a full preclinical toxicology study?
• How has CBI adapted its services in response to emerging infectious diseases?

We are here to guide you every step of the way, ensuring that your research journey is as smooth and successful as possible.